Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWorldsec Regulatory News (WSL)

Share Price Information for Worldsec (WSL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 0.75
Ask: 1.75
Change: 0.00 (0.00%)
Spread: 1.00 (133.333%)
Open: 1.25
High: 1.25
Low: 1.25
Prev. Close: 1.25
WSL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

30 Apr 2014 14:51

RNS Number : 9501F
Worldsec Ld
30 April 2014
 



 

 

Worldsec Limited

Preliminary Statement of Annual Results

 

 

Worldsec Limited is pleased to release today its preliminary statement of annual results for the year ended 31 December 2013.

 

The Chairman's Statement and extracts from the audited financial statements are reproduced below.

 

Investor Relations

 

For further information please contact:

 

In Hong Kong

Mr. Henry Ying Chew CHEONG

Executive Director and Deputy Chairman

+852 2971 4280

 

 

CHAIRMAN'S STATEMENT

RESULTS

 

The audited consolidated loss of Worldsec Limited (the "Company"), and its subsidiaries (together the "Group") for the financial year 2013 was US$273,000, compared with a loss of US$304,000 in 2012. Loss per share was US 1 cent (2012: US 2 cents). 

REVIEW

 

I am pleased to report that, with the shareholders' approval and support, the Company successfully completed its fund raising exercise in September 2013.

 

Through the open offer of 13,367,290 new shares to shareholders and the placing of 30,000,000 new shares to independent third-party investors at the issue price of US 10 cents per share, the Company has raised new equity capital of approximately US$4.3 million before expenses. As at 31 December 2013, the net assetsof the Group amounted to approximately US$4.2 million (2012: US$0.6 million), equivalent to approximately US 8 cents per share.

 

As explained in the fund raising documents, the purpose of the fund raising was to facilitate the reactivation of the business activities of the Group in order to invest primarily in smaller unlisted businesses based mainly in Greater China and the South East Asian region with a view to participating and benefiting from the investment opportunities from these relatively fast growing economies. In this connection, the Company has:

 

- appointed Messrs Ernest Chiu Shun She and Martyn Stuart Wells as executive and non-executive directors respectively to strengthen the Board;

- re-established the Audit Committeeand the Remuneration Committee;

 

- reviewed, and where appropriate, revised the Group's internal control procedures; and

 

- put in place an operational structure to conduct its new investment business activities.

 

These measures have repositioned the Group to pursue its investment strategy in accordance with the new investment policy approved by shareholders in connection with the fund raising exercise.

 

PROSPECTS

 

The Board has since the approval by shareholders of the new investment policy actively looked for investment opportunities. With theincrease in the Company's share capital, the strengthening of the Board with two additional directors, and a new operation structure, the Group is prepared to start a new chapter in its investment business activities. The Board, barring unforeseen circumstances and provided that suitable business propositions can be identified, aims to make two investments during the financial year 2014.

 

 

 

 

Alastair GUNN-FORBES

Non-Executive Chairman

30 April 2014

 

 

CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER

COMPREHENSIVE INCOME

FOR THE YEAR ENDED 31 DECEMBER 2013

 

 

Year ended 31 December

Notes

2013

2012

US$'000

US$'000

Turnover

-

-

Finance costs

-

-

Staff costs

3

(45)  

(16)

Other expenses

(228)

(288)

Loss before tax

4

(273)  

(304)

Income tax expense

5

-

-

Loss for the year

(273)  

(304)

Other comprehensive income, net of income tax

Items that may be reclassified subsequently to profit or loss:

Exchange differences on translating foreign operations

 

2

 

1

 

Other comprehensive income for the year, net of income tax

 

2

 

1

Total comprehensive expense for the year

 

(271)

(303)

 

Loss attributable to :

Owners of the Company

(273)

(304)

Total comprehensive expense attributable to :

Owners of the Company

(271)

(303)

Loss per share - basic and diluted

6

(1) cent

(2) cents

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AT 31 DECEMBER 2013

 

 

Notes

2013

2012

 

US$'000

US$'000

 

 

Current assets

 

Cash and cash equivalents

4,702

909

 

 

Current liabilities

 

Other payables and accruals

(458)  

(275)

 

 

Net assets

4,244

634

 

 

Capital and reserves

 

Share capital

7

57

13

 

Share premium

3,837

-

 

Contributed surplus

9,646

9,646

 

Foreign currency translation reserve

Special reserve

(2)  

625

(4)

625

 

Accumulated losses

(9,919)  

(9,646)

 

 

Total equity

4,244

634

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF changes in equity

FOR THE YEAR ENDED 31 DECEMBER 2013

 

 

Foreign

currency

Share

Share

Contributed

translation

Special

Accumulated

capital

premium

surplus

reserve

reserve

losses

Total

US$'000

US$'000

US$'000

US$'000

US$'000

US$'000

US$'000

Balance at 1 January 2012

13

-

9,646

(5)

625

(9,342)

937

 

Loss for the year

Other comprehensive income for the year

 

-

-

 

-

-

 

-

-

 

-

1

 

-

-

 

(304)

-

 

(304)

1

 

Total comprehensive

 expense for the year

 

 

-

 

 

-

 

 

-

 

 

1

 

 

-

 

 

(304)

 

 

(303)

Balance at 31 December 2012 and 1 January 2013

 

13

-

 

9,646

 

(4)

 

625

 

(9,646)

 

634

 

Loss for the year

 

-

-

 

-

 

-

 

-

 

(273)

 

(273)

Other comprehensive income for the year

-

-

-

2

-

-

2

Total comprehensive expense for the year

-

-

-

2

-

(273)

(271)

 

Issue of new shares by way of placing

 

 

44

 

 

4,293

 

 

-

 

 

-

 

 

-

 

 

-

 

 

4,337

Transaction costs attributable to issue of new shares

 

 

-

 

 

(456)

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(456)

Balance at 31 December 2013

57

 

3,837

9,646

 

(2)

625

(9,919)

4,244

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2013

 

 

Year ended 31 December

2013

2012

US$'000

US$'000

Cash flows from operating activities

Loss for the year

(273)

(304)

(273)  

(304)

Movements in working capital

Increase/(decrease) in other payables and accruals

183

(5)

Net cash used in operating activities

(90)

(309)

Cash flows from financing activities

Proceeds from issue of new shares

4,337

-

Payment for share issue costs

(456)

-

Net cash from financing activities

3,881

-

Net increase/(decrease) in cash and cash equivalents

3,791

(309)

Cash and cash equivalents at the beginning of the year

909

1,217

 

Effects of exchange rate changes

 

 2

 

1

Cash and cash equivalents at the end of the year

 4,702

909

 

 

 

 

 

 

 

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2013

 

 

1. Application OF NEW AND REVISED INTERNATIONAL FINANCIAL REPORTING STANDARDS ("IFRSs")

 

1.1 New and revised IFRSs applied with no material effect on the consolidated financial statements

 

The following new and revised IFRSs have been applied by the Group in the current year and have affected the presentation and disclosures set out in these consolidated financial statements. The application of these new and revised IFRSs has not had any material impact on the amounts reported for the current and prior years.

 

 

IFRSs (Amendments) Annual improvements to IFRSs 2009-2011 cycle except for

the amendments to IAS 1

IAS 1 (Amendments) Presentation of Items of Other Comprehensive Income

IAS 19 (as revised in 2011) Employee BenefitsIFRS 7 (Amendments) Disclosures - Offsetting Financial Assets and Financial Liabilities

IFRS 10 Consolidated Financial Statements

IFRS 12 Disclosure of Interests on Other EntitiesIFRS 13 Fair Value Measurement

Except as described below, the application of the above new and revised IFRSs in the current year has had no material impact on the Group's financial performance and positions for the current and prior years and/or on the disclosures set out in these consolidated financial statements.

 

Amendments to IAS 1 Presentation of Items of Other Comprehensive Income

 

The Group has applied the amendments to IAS 1 Presentation of Items of Other Comprehensive Income for the first time in the current year. The amendments introduce new terminology, whose use is not mandatory, for the statement of comprehensive income and income statement. Under the amendments to IAS 1, the 'statement of comprehensive income' is renamed as the 'statement of profit or loss and other comprehensive income'. The amendments to IAS 1 retain the option to present profit or loss and other comprehensive income in either a single statement or in two separate but consecutive statements. However, the amendments to IAS 1 require items of other comprehensive income to be grouped into two categories in the other comprehensive section: (a) items that will not be reclassified subsequently to profit or loss and (b) items that may be reclassified subsequently to profit or loss when specific conditions are met. Income tax on items of other comprehensive income is required to be allocated on the same basis - the amendments do not change the option to present items of other comprehensive income either before tax or net of tax. The amendments have been applied retrospectively, and hence the presentation of items of other comprehensive income has been modified to reflect the changes. Other than the above mentioned presentation changes, the application of the amendments to IAS 1 does not result in any impact on profit or loss, other comprehensive income and total comprehensive income.

 

 

 

1.2 New and revised IFRSs in issue but not yet effective

 

The Group has not applied the following new and revised IFRSs that have been issued but are not yet effective:

 

IAS 16 Property, plant and equipment1

IAS 19 Employee Benefits1

IAS 24 Related Party Disclosures1

IAS 27 Separate Financial Statements2

IAS 32 (Amendments) Financial Instruments: Presentation - Offsetting

Financial Assets and Financial Liabilities2

IAS 36 Impairment of Assets2

IAS 38 Intangible Assets1

IAS 39 Financial Instruments: Recognition and Measurement2

IAS 40 Investment Property1

IFRS 2 Share-based Payment1

IFRS 3 (as revised in 2008) Business Combinations1

IFRS 8 Operating Segments1

IFRS 9 Financial Instruments3

IFRS 9 and IFRS 7 Mandatory Effective Date of IFRS 9 and Transition

Disclosures3

IFRS 10, 12 and IAS 27 Investment Entities2

 2011 (Amendments)

IFRS 14 Regulatory Deferral Accounts4

IFRIC 21 Levies2

 

1 Effective for annual periods beginning on or after 1 July 2014

2 Effective for annual periods beginning on or after 1 January 2014

3 Effective for annual periods beginning on or after 1 January 2015

4 Effective for annual periods beginning on or after 1 January 2016

 

 

IFRS 9 issued in November 2009 introduced new requirements for the classification and measurement of financial assets. IFRS 9 was amended in October 2010 to include requirements for the classification and measurement of financial liabilities and for derecognition.

 

 

Key requirements of IFRS:

 

· All recognized financial assets that are within the scope of IAS 39 Financial Instruments: Recognition and Measurement are required to be subsequently measured at amortized cost or fair value. Specifically, debt investments that are held within a business model whose objective is to collect the contractual cash flows, and that have contractual cash flows that are solely payments of principal and interest on the principal outstanding are generally measured at amortized cost at the end of subsequent accounting periods. All other debt investments and equity investments are measured at their fair values at the end of subsequent accounting periods.

 

· With regard to the measurement of financial liabilities designated as at fair value through profit or loss, IFRS 9 requires that the amount of change in the fair value of the financial liability that is attributable to changes in the credit risk of that liability is presented in other comprehensive income, unless the recognition of the effects of changes in the liability's credit risk in other comprehensive income would create or enlarge an accounting mismatch in profit or loss. Changes in fair value attributable to a financial liability's credit risk are not subsequently reclassified to profit or loss. Under IAS 39, the entire amount of the change in the fair value of the financial liability designated as at fair value through profit or loss is presented in profit or loss.

 

The directors anticipate that the application of IFRS 9 in the future may have a significant impact on amounts reported in respect of the Group's financial assets and financial liabilities. However, it is not practicable to provide a reasonable estimate of the effect of IFRS 9 until a detailed review has been completed.

 

 

2. SEGMENT Information

 

No segment analysis is presented for the years ended 31 December 2013 and 2012 as the Group has only maintained a minimum operation during both years.

 

 

 

3. STAFF COSTS

 

The aggregate cost of persons employed by the Group was as follows:

 

Year ended 31 December

2013

2012

US$'000

US$'000

Wages and salaries

45

16

Directors' remuneration was as follows:

Year ended 31 December

2013

2012

US$'000

US$'000

Fees

45

16

Other remuneration including

contributions to pension and provident fund

-

-

45

16

 

 

4. LOSS BEFORE TAX

 

Loss before tax has been arrived at after charging:

Year ended 31 December

2013

2012

US$'000

US$'000

Auditors' remuneration

41

22

Net foreign exchange loss

1

-

 

 

5. INCOME TAX EXPENSE

 

No provision for taxation had been made as the Group did not generate any assessable profit for UK Corporation Tax, Hong Kong Profits Tax and tax in other jurisdictions.

 

The tax charge for year 2013 and 2012 can be reconciled to the loss before tax per the consolidated statement of profit or loss and other comprehensive income as follows:

 

Year ended 31 December

2013

 

2012

US$'000

US$'000

Loss before tax

273

304

 

Loss before tax calculated at 16.5% (2012:16.5%)

45

50

Tax effect of estimated tax losses not recognized

(45)

(50)

Tax charge for the year

-

-

 

No deferred tax had been recognized in the financial statements as the Group and the Company did not have material temporary difference arising between the tax bases of assets and liabilities and their carrying amounts as at 31 December 2013 and 2012.

 

 

 

 

6. LOSS PER SHARE

The loss and weighted average number of ordinary shares used in the calculation of basic and diluted loss per share were as follows.

 

Year ended 31 December

2013

 

2012

Loss for the year attributable to owners of the Company

US$273,000

US$304,000

 

Weighted average number of ordinary shares for the purposes of basic and diluted loss per share

27,387,400

13,367,290

 

Loss per share - basic and diluted

1 cent

2 cents

 

 

 

7. SHARE CAPITAL

 

2013

2012

US$

US$

Authorized:

60,000,000,000 (2012: 50,000,000,000)

ordinary shares of US$0.001 each

 

60,000,000

 

50,000,000

Number of

shares

Total value

US$'000

 

At 1 January 2012, 31 December 2012

and 1 January 2013

 

 

 

50,000,000,000

 

50,000

Additions during the year (Note i)

10,000,000,000

10,000

At 31 December 2013

60,000,000,000

60,000

Called up, issued and fully paid:

56,734,580 (2012: 13,367,290)

ordinary shares of US$0.001 each

 

56,735

 

13,367

Number of shares

Total value

US$'000

 

At 1 January 2012, 31 December 2012

and 1 January 2013

 

 

 

13,367,290

 

13,367

Issue of new shares by way of placing (Note ii)

30,000,000

30,000

Issue of new shares by way of open offer (Note iii)

13,367,290

13,368

At 31 December 2013

56,734,580

56,735

 

Notes:

 

(i) Pursuant to the ordinary resolution passed on 30 August 2013, the authorized share capital of the Company was increased from US$50,000,000 divided into 50,000,000,000 ordinary shares of US$0.001 each to US$60,0000,000 divided into 60,000,000,000 ordinary shares of US$0.001 each by the creation of an additional 10,000,000,000 ordinary shares of US$0.001 each.

 

(ii) In September 2013, the Company issued 30,000,000 ordinary shares of US$0.001 each in the share capital of the Company at a price of US$0.10 per share by way of placing to independent investors, giving rise to gross proceeds of US$3 million.

 

(iii) In September 2013, the Company issued 13,367,290 ordinary shares of US$0.001 each in the share capital of the Company at a price of US$0.10 per share by way of open offer on the basis of 1 new share for every 1 ordinary share held by qualifying shareholders, giving rise to gross proceeds of US$1.3 million.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR LLFSVSSIIVIS
12
Date   Source Headline
28th Sep 20232:33 pmRNSHalf-year Report
30th Jun 20234:38 pmRNSResult of AGM
27th Apr 20232:38 pmRNSAnnual Financial Report Year End 31 December 2022
20th Feb 20237:30 amRNSDirector/PDMR Shareholding
11th Nov 20223:30 pmRNSResult of AGM
27th Sep 20225:38 pmRNSHalf-year Report
16th Sep 202210:56 amRNSTrading Statement
27th Apr 20227:00 amRNSAnnual Report for the year ended 31 December 2021
26th Nov 20212:54 pmRNSResult of AGM
27th Sep 20212:23 pmRNSHalf-year Report for period ended 30 June 2021
30th Apr 20211:39 pmRNSAnnual Report for the year ended 31 December 2020
1st Apr 20212:05 pmRNSTrading Statement
26th Nov 20203:39 pmRNSResult of AGM
25th Sep 20202:07 pmRNSHalf-year Report for period ended 30 June 2020
24th Apr 20206:16 pmRNSAnnual Report for the year ended 31 December 2019
26th Sep 201910:23 amRNSHalf-year Report
12th Jul 20195:31 pmRNSResult of AGM
3rd Jun 201911:56 amRNSAppointment of Director
29th May 20191:30 pmRNSDirector/PDMR Shareholding
29th Apr 201912:39 pmRNSAnnual Report for the year ended 31 December 2018
2nd Nov 20183:12 pmRNSResult of AGM
24th Oct 201811:46 amRNSHolding(s) in Company
24th Oct 201811:40 amRNSHolding(s) in Company
3rd Oct 201810:05 amRNSPublication of Supplementary Prospectus
28th Sep 201812:35 pmRNSHalf-year Report
15th May 201811:34 amRNSPublication of Supplementary Prospectus
30th Apr 201811:45 amRNSAnnual Report for the year ended 31 December 2017
9th Apr 201811:48 amRNSDirector/PDMR Shareholding
3rd Apr 20181:40 pmRNSResult of Open Offer
13th Mar 20182:58 pmRNSOpen Offer and Publication of Prospectus
29th Nov 201711:00 amRNSResult of AGM
25th Sep 20173:03 pmRNSHalf-year Report
28th Apr 201712:34 pmRNSAnnual Financial Report 2016
28th Oct 20167:45 amRNSResult of AGM
2nd Sep 20162:34 pmRNSHalf-year Report
29th Apr 20165:50 pmRNSAnnual Financial Report 2015
1st Dec 201511:29 amRNSGrant of Options
6th Oct 201511:53 amRNSResult of AGM
28th Aug 20159:50 amRNSInterim Report - six months ended 30 June 2015
23rd Apr 20152:46 pmRNSAnnual Report for the year ended 31 December 2014
25th Feb 20151:29 pmRNSChange of Auditor and Principal Place of Business
12th Dec 201411:19 amRNSInvestment Update
28th Nov 20148:43 amRNSInvestment Update
30th Sep 20149:03 amRNSResult of AGM
28th Aug 20141:40 pmRNSHalf Yearly Report
30th Apr 20142:51 pmRNSFinal Results
13th Feb 201411:21 amRNSChange of Auditor
10th Dec 201312:32 pmRNSResult of Equity Issue - correction
30th Aug 20131:02 pmRNSResult of Equity Issue
30th Aug 201312:55 pmRNSResult of EGM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.